| Source |
In-Depth |
Reliable |
Comments |
| https://www.darkdaily.com/laboratory-resources-2/revenue-cycle-systems-and-services/ligolab-information-system/ |
YES |
YES |
Article from a reliable Clinical lab publication that posts news and reviews Lab related companies. This is a very long review and definitely considered significant coverage. |
| https://www.medlabmag.com/article/1687 |
YES |
YES |
Peer review website |
| https://www.captodayonline.com/newsbytes-1120/ |
YES |
YES |
This is a very vey in-depth article. Contains a few quotations, but they are less than 5% of the overall content. |
| https://www.mlo-online.com/information-technology/lis/article/21132383/ligolab-provides-its-lis-at-no-cost-to-labs-implementing-covid19-testing |
YES |
YES |
This is an in-dept article. |
| https://medcitynews.com/2021/08/molecular-labs-hold-the-key-to-evidence-based-precision-medicine/ |
NO |
YES |
One paragraph info about them + 2 quotations |
| https://www.capterra.com/p/95392/LigoLab-Station/ |
YES |
YES |
This is a business software review site. It has a very in-depth review. There are no affiliate links. |
| https://www.modernhealthcare.com/supply-chain/covid-driving-labs-build-out-information-systems |
YES |
YES |
Not entirely about LigoLab, but has at least 5 paragraphs of info about them, so it's not a passing mention. |
| https://www.360dx.com/clinical-lab-management/telehealth-space-expands-companies-move-secure-lab-capabilities#.YlTSx8jMIuW |
NO |
YES |
2 Paragraphs of info about the company. It is behind a paywall, but if you view source code and search for Ligolab, you will find the relevant sections. |
| https://www.inc.com/profile/ligolab-information-systems |
NO |
YES |
Not much info here, but making it to Inc5000 is significant in itself for notability. it is a major award. |
| https://clpmag.com/disease-states/infectious-diseases/covid-19/testdirectly-web-portal-simplifies-workflows-improves-turnaround-times/ |
YES |
YES |
in-depth Article |
| https://clpmag.com/disease-states/infectious-diseases/covid-19/florida-to-test-all-of-the-states-long-term-care-residents-and-staff-for-covid-19/ |
YES |
YES |
In-depth coverage and very significant. Couple of quotations exist, but they are less than 10% of the total article. |
| https://clpmag.com/disease-states/infectious-diseases/covid-19/lab-detects-uk-covid-19-variant-with-pcr-test-confirmed-with-rna-sequencing/ |
NO |
YES |
Not entirely about Ligolab, but has a couple of sections of info about them. |
| https://www.aacc.org/cln/articles/2021/november/the-lab-is-moving-from-a-black-box-to-a-smartphone-app |
YES |
YES |
4 paragraphs of info on Liglab, one paragraph is a quote. I would consider 3 paragraphs or more to be significant and not a passing mention. |
| https://clpmag.com/lab-essentials/information-technology/ligolabs-lis-and-rcm-maximizes-clean-claims-lab-payments/ |
Maybe |
YES |
220 Words info about them. Not a passing mention. |
| https://medcitynews.com/2021/02/how-text-messaging-is-transforming-the-life-sciences-industry/ |
NO |
YES |
3 paragraphs info, one paragraph a quotation. I would not call it in-depth |
| https://www.darkintelligencegroup.com/the-dark-report/laboratory-management/pathology-lab-transforms-runs-1m-covid-19-tests/ |
NO |
YES |
Passing mention |
.svg){kind=small}
